MEGAN MULLIN: Open Payments
NPI 1265862510 · PHILADELPHIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$881 in 24 payments from 10 companies in 2025. Trend: 2023 $364 · 2024 $551 · 2025 $881
Food & beverage: $667Education: $214
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 6 | $315 |
| ABIOMED | 5 | $193 |
| Baxter Healthcare | 1 | $79 |
| Haemonetics Corporation | 1 | $63 |
| La Jolla Pharmaceutical Company | 2 | $49 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 3 | $47 |
| Solventum Corporation | 2 | $39 |
| AtriCure, Inc. | 2 | $35 |
| Becton, Dickinson and Company | 1 | $31 |
| Avanos Medical | 1 | $29 |
Products named: Cresemba, PREVELEAK, TEG6S HEMOSTASIS SYSTEM, GIAPREZA, LifeVest, V.A.C.ULTA, HemoSphere, CORTRAK.
Industry payments across PA — which companies pay providers there.
